03:28 AM EST, 02/14/2025 (MT Newswires) -- Andrew D Dickinson, Chief Financial Officer, on February 12, 2025, sold 137,676 shares in Gilead Sciences ( GILD ) for $14,073,241. Following the Form 4 filing with the SEC, Dickinson has control over a total of 171,223 common shares of the company, with 171,223 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000112760225004784/xslF345X05/form4.xml